{"id":"W3122395164","doi":"10.1200/jco.2021.39.3_suppl.164","title":"Zanidatamab (ZW25) in HER2-expressing gastroesophageal adenocarcinoma (GEA): Results from a phase I study.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Zymeworks (Canada); Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Capecitabine; Medicine; Tolerability; Trastuzumab; Immunohistochemistry; Internal medicine; Paclitaxel; Chemotherapy; Oncology; Cancer; Breast cancer; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001577934,0.001142857,0.001416076,0.0004212246,0.0003117402,0.000868472,0.000892326,0.0009535195,0.003498987],"category_scores_gemma":[0.0006469237,0.0005244411,0.001566263,0.0004953615,0.0005870448,0.0006483393,0.0003081518,0.001736938,0.001158817],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008385149,"about_ca_system_score_gemma":0.001457839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001901662,"about_ca_topic_score_gemma":0.006404146,"domain_scores_codex":[0.9996868,0.0001319911,0.00002410973,0.00005294339,0.00003825339,0.00006590055],"domain_scores_gemma":[0.9996177,0.00004854119,0.00008535354,0.00002772573,0.00002202895,0.0001985875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4139169,0.09217903,0.02124901,0.003454166,0.007077583,0.00136747,0.0008118614,0.005008284,0.1264874,0.0005744439,0.0204395,0.3074344],"study_design_scores_gemma":[0.5337574,0.3932083,0.04806632,0.0001767628,0.00257083,0.001378442,0.0001507328,0.001125177,0.007074002,0.000300327,0.0121298,0.00006184883],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9743123,0.01441922,0.0008215861,0.0006721189,0.000149635,0.002923491,0.003788967,0.0001235997,0.002789011],"genre_scores_gemma":[0.9705165,0.01160137,0.002101382,0.001421614,0.0001318115,0.001770564,0.009207502,0.00005362338,0.003195562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003498987,"threshold_uncertainty_score":0.01170534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1467447921575289,"score_gpt":0.4807053222383106,"score_spread":0.3339605300807817,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}